Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elongation of administration interval of bone modifying agents in lung cancer patients with bone metastases
jRCTs021240060Not yet recruiting
- Start
- Feb 2025
- Countries
- 1
01
Overview
Open-label trial in bronchial carcinoma and bone metastases (2 arms). Planned start Feb 2025; status: not yet recruiting.
02
Conditions
bronchial carcinomabone metastases
Beyond the preview
Go deeper on jRCTs021240060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021240060.